Fig. 8
From: Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatment
Molecular and ERS1 target part docking results(a represents the docking result of MOL005384 with the target, b represents the docking result of MOL00727 with the target, c represents the docking result of MOL000471 with the target, d represents the docking result of MOL000787 with the target, e represents the docking result of MOL001792 with the target, f represents the docking result of MOL002235 with the target, g represents the docking result of MOL002268 with the target, h represents the docking result of MOL000354 with the target)